JiangSu WuZhong Pharmaceutical Development Co Ltd banner

JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200

Watchlist Manager
JiangSu WuZhong Pharmaceutical Development Co Ltd Logo
JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200
Watchlist
Price: 0.29 CNY Market Closed
Market Cap: ¥881.5m

Wall St Price Targets

Price Targets Summary
JiangSu WuZhong Pharmaceutical Development Co Ltd

There are no price targets for JiangSu WuZhong Pharmaceutical Development Co Ltd.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
JiangSu WuZhong Pharmaceutical Development Co Ltd Competitors:
Price Targets
CXT
Crane NXT Co
86% Upside
MZH
Nanofilm Technologies International Ltd
-5% Downside

Revenue
Forecast

-7% / Year
Past Growth
48% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-7% / Year
Past Growth
48% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 2 years is 48%.

Gross Profit
Forecast

8% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
8% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%.

Operating Income
Forecast

8% / Year
Past Growth
127% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
8% / Year
Past Growth
127% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 2 years is 127%.

Pre-Tax Income
Forecast

0% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
0% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%.

Net Income
Forecast

7% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
7% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 7%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is JiangSu WuZhong Pharmaceutical Development Co Ltd's stock price target?
Not Available

JiangSu WuZhong Pharmaceutical Development Co Ltd does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for JiangSu WuZhong Pharmaceutical Development Co Ltd?
Projected CAGR
48%

Over the last 13 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 2 years is 48%.

What is the Operating Income forecast for JiangSu WuZhong Pharmaceutical Development Co Ltd?
Projected CAGR
127%

Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 2 years is 127%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett